Pathosense SRL
7.3 FTEThe score of Pathosense shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +180 % Headcount (avg FTE) +33 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Pathosense's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 94,137 € | ||||
| Equity | 157,114 € | ||||
| Cash | 221,036 € | ||||
| EBITDA | 235,450 € | ||||
| Total assets | €1.21m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Mar 2026
- Year ended 31 Dec 2024filed on 02 Jul 2025
- Year ended 31 Dec 2023filed on 27 Sep 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 18 Jul 2022
Pathosense's financial analysis
- Solvency13.0%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pathosense
Pathosense's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0755.557.744
- VAT number
- BE0755557744
- Peppol
- Registered · 0208:0755557744 · as of 27 Oct 2026
- Legal form
- SRL
- Incorporated
- 01 Oct 2020
- Registered office
- 2500 Lier
- Size
- Micro · 7.3 FTE
- Latest accounts
- 2025 · filed on 27 Mar 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Pathosense (SRL) has been based in Lier since 2020, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 94,137 € and equity of 157,114 €; its revenue is not published. With 7.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 13.0%, below the median of its sector (60.4%).
Companies similar to Pathosense
Companies in the same business, of comparable size and area, outside its group.
- InnoSer België Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet €2.12m
- care2trans Research and experimental development on natural sciences and engineering Merelbeke-Melle · balance sheet 817,653 €
- Lavima fertility Research and experimental development on natural sciences and engineering Aalst · balance sheet 863,324 €
- Apr. Biol. Inger Brandt Research and experimental development on natural sciences and engineering Lebbeke · balance sheet €2.44m
- Sicher Research and experimental development on natural sciences and engineering Balen · balance sheet 246,186 €
- Cell-Cell BIO Research and experimental development on natural sciences and engineering Ghent · balance sheet 990,571 €
- Spectralys Biotech Research and experimental development on natural sciences and engineering Charleroi · balance sheet 444,695 €
- Dokter Chielens Research and experimental development on natural sciences and engineering Poperinge · balance sheet €1.30m
Frequently asked questions about Pathosense
What is the revenue of Pathosense?
Pathosense files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pathosense?
In Belgium, the VAT number is the company number prefixed with BE: BE0755557744 for Pathosense, if the company is VAT-registered. Its company number (CBE) is 0755.557.744.
Where is the registered office of Pathosense?
According to the CBE register, the registered office of Pathosense is in 2500 Lier.
What is the equity of Pathosense?
At the close of the 2025 financial year, the equity of Pathosense amounts to 157,114 €, a solvency of 13.0% of total assets.
How many people work at Pathosense?
7.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pathosense?
The register lists 2 active mandates at Pathosense. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pathosense
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →